Importantly, this study did not find a link between GLP-1 medications and NAION.
Medically supervised weight loss
This review delves into the pathogenesis of diabetes mellitus and CKD, highlighting the unique challenges these complications present in liver transplant recipients
However, further studies have revealed that -cells in the pancreatic islets, and neurons in the nucleus of the solitary tract are also able to produce GLP-1
Your GLP-1 prescription qualifies when it is treating one of these documented conditions: Type 2 diabetes Clinical obesity with a comorbidity (hypertension, sleep apnea, cardiovascular disease, or high cholesterol) Prediabetes or insulin resistance Polycystic ovary syndrome (PCOS) Non-alcoholic fatty liver disease (NAFLD) The critical requirement is documentation
About Novo Nordisk Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years